Free Trial

National Vision (EYE) Competitors

National Vision logo
$22.64 -1.53 (-6.33%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$22.64 0.00 (-0.02%)
As of 09:25 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EYE vs. NVST, STVN, GKOS, BLCO, SLNO, IRTC, INSP, TMDX, PRCT, and WRBY

Should you be buying National Vision stock or one of its competitors? The main competitors of National Vision include Envista (NVST), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), Inspire Medical Systems (INSP), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry.

National Vision vs. Its Competitors

Envista (NYSE:NVST) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.

Envista currently has a consensus price target of $20.92, indicating a potential upside of 3.25%. National Vision has a consensus price target of $24.73, indicating a potential upside of 9.22%. Given National Vision's stronger consensus rating and higher probable upside, analysts clearly believe National Vision is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
1 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.33
National Vision
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.60

National Vision has lower revenue, but higher earnings than Envista. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.51B1.34-$1.12B$0.3263.33
National Vision$1.82B0.98-$28.50M-$0.18-125.78

Envista has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.Comparatively, National Vision has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500.

Envista has a net margin of 2.11% compared to National Vision's net margin of -0.75%. Envista's return on equity of 4.84% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista2.11% 4.84% 2.68%
National Vision -0.75%3.56%1.49%

In the previous week, National Vision had 14 more articles in the media than Envista. MarketBeat recorded 24 mentions for National Vision and 10 mentions for Envista. National Vision's average media sentiment score of 1.04 beat Envista's score of 0.75 indicating that National Vision is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
National Vision
8 Very Positive mention(s)
10 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Envista beats National Vision on 8 of the 15 factors compared between the two stocks.

Get National Vision News Delivered to You Automatically

Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EYE vs. The Competition

MetricNational VisionCONS PD IndustryStaples SectorNASDAQ Exchange
Market Cap$1.79B$32.12B$16.01B$9.71B
Dividend YieldN/A2.69%3.17%4.12%
P/E Ratio-125.7834.2618.6224.69
Price / Sales0.981.7345.75104.79
Price / Cash13.8416.1514.6828.01
Price / Book2.188.476.095.76
Net Income-$28.50M$1.23B$681.87M$267.05M
7 Day Performance-9.69%-0.13%0.66%3.13%
1 Month Performance-7.44%-2.06%-3.27%1.27%
1 Year Performance120.23%26.71%6.03%22.83%

National Vision Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EYE
National Vision
2.9992 of 5 stars
$22.64
-6.3%
$24.73
+9.2%
+120.2%$1.79B$1.82B-125.7813,411Positive News
Earnings Report
Analyst Upgrade
NVST
Envista
3.4958 of 5 stars
$20.73
-0.3%
$20.23
-2.4%
+25.2%$3.53B$2.51B-3.1712,300
STVN
Stevanato Group
2.0671 of 5 stars
€25.77
-2.8%
N/A+15.3%€7.80B€1.19B50.535,521Positive News
Analyst Revision
GKOS
Glaukos
3.9357 of 5 stars
$94.80
+0.5%
$134.67
+42.1%
-30.3%$5.39B$383.48M-40.00780Positive News
BLCO
Bausch + Lomb
2.7864 of 5 stars
$14.47
+1.0%
$15.45
+6.8%
-13.1%$5.07B$4.79B-14.0513,500
SLNO
Soleno Therapeutics
4.5554 of 5 stars
$85.25
-1.4%
$108.70
+27.5%
+79.4%$4.36BN/A-18.4530Positive News
Earnings Report
Analyst Revision
IRTC
iRhythm Technologies
1.7583 of 5 stars
$137.11
+2.2%
$137.30
+0.1%
+123.3%$4.28B$591.84M-43.672,000
INSP
Inspire Medical Systems
4.632 of 5 stars
$130.72
+1.4%
$208.55
+59.5%
-59.0%$3.80B$802.80M60.241,246Positive News
Earnings Report
TMDX
TransMedics Group
2.2688 of 5 stars
$105.24
-2.7%
$129.88
+23.4%
-29.7%$3.66B$441.54M77.38210
PRCT
PROCEPT BioRobotics
3.4214 of 5 stars
$54.08
-2.9%
$84.13
+55.6%
-37.2%$3.08B$224.50M-31.81430Earnings Report
Analyst Upgrade
Analyst Revision
Gap Up
WRBY
Warby Parker
1.9899 of 5 stars
$24.10
-1.2%
$22.88
-5.1%
+77.6%$2.55B$771.32M-200.833,780Analyst Forecast
Gap Up

Related Companies and Tools


This page (NASDAQ:EYE) was last updated on 8/11/2025 by MarketBeat.com Staff
From Our Partners